These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459 [TBL] [Abstract][Full Text] [Related]
4. Analysis of expression and soluble form of intercellular adhesion molecule-1 in malignant melanoma. Kageshita T; Yoshii A; Kimura T; Ono T J Dermatol; 1992 Nov; 19(11):836-40. PubMed ID: 1284075 [TBL] [Abstract][Full Text] [Related]
5. Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma. Miller JG; Gee J; Price A; Garbe C; Wagner M; Mac Neil S Melanoma Res; 1997 Jun; 7(3):197-208. PubMed ID: 9195558 [TBL] [Abstract][Full Text] [Related]
6. Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis. Krisp C; Parker R; Pascovici D; Hayward NK; Wilmott JS; Thompson JF; Mann GJ; Long GV; Scolyer RA; Molloy MP Br J Cancer; 2018 Sep; 119(6):713-723. PubMed ID: 30116025 [TBL] [Abstract][Full Text] [Related]
8. Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma. Oba J; Nakahara T; Hayashida S; Kido M; Xie L; Takahara M; Uchi H; Miyazaki S; Abe T; Hagihara A; Moroi Y; Furue M J Am Acad Dermatol; 2011 Dec; 65(6):1152-60. PubMed ID: 21700362 [TBL] [Abstract][Full Text] [Related]
9. Is sentinel node status predictive of overall survival in patients with melanoma? Carlson GW Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765 [No Abstract] [Full Text] [Related]
10. Pathology of malignant melanoma. Heasley DD; Toda S; Mihm MC Surg Clin North Am; 1996 Dec; 76(6):1223-55. PubMed ID: 8977548 [TBL] [Abstract][Full Text] [Related]
11. Overall survival and PD-L1 expression in metastasized malignant melanoma. Gadiot J; Hooijkaas AI; Kaiser AD; van Tinteren H; van Boven H; Blank C Cancer; 2011 May; 117(10):2192-201. PubMed ID: 21523733 [TBL] [Abstract][Full Text] [Related]
12. Establishment of a melanoma cell line with metastatic characteristics. Enjoji M; Nakashima M; Sakai H; Nawata H Hum Cell; 1995 Sep; 8(3):115-20. PubMed ID: 8652447 [TBL] [Abstract][Full Text] [Related]
13. Tenascin-C in primary malignant melanoma of the skin. Ilmonen S; Jahkola T; Turunen JP; Muhonen T; Asko-Seljavaara S Histopathology; 2004 Oct; 45(4):405-11. PubMed ID: 15469480 [TBL] [Abstract][Full Text] [Related]
14. Kinetics analysis of binding between melanoma cells and neutrophils. Hoskins MH; Dong C Mol Cell Biomech; 2006 Jun; 3(2):79-87. PubMed ID: 16903259 [TBL] [Abstract][Full Text] [Related]
15. Increase in shedding of intercellular adhesion molecule-1 in human malignant melanoma cell lines treated with hyperthermia in vitro. Nakayama J; Kageshita T; Nakashima M; Tsujisaki M; Imai K; Hori Y Pigment Cell Res; 1996 Jun; 9(3):154-8. PubMed ID: 8888315 [TBL] [Abstract][Full Text] [Related]
16. [Stage I cutaneous melanoma. Clinical and epidemiological findings on 313 cases]. Reali UM; Bondi R; Giannotti B G Ital Dermatol Venereol; 1987 Dec; 122(12):609-17. PubMed ID: 3447992 [No Abstract] [Full Text] [Related]
17. [Correlation between the degree of histological progression (according to Clark and Breslow) and prognosis in cases of malignant melanoma stage I (T1-3, No, Mo)]. Kwiatkowska W; Dabska M Nowotwory; 1983; 33(2):149-52. PubMed ID: 6664885 [No Abstract] [Full Text] [Related]
18. Surgical management of cutaneous melanoma: current practice and impact on prognosis. Mosca PJ; Tyler DS; Seigler HF Adv Surg; 2004; 38():85-119. PubMed ID: 15515616 [No Abstract] [Full Text] [Related]